Scientific work

Dr. Öğr. Üyesi Olgu Erkin Çınar

37 publications. The source of the information is stated next to each publication.

Back to profile

  1. Cardio-Hematology Crossroads: A Diffuse Large B-Cell Lymphoma Case Presenting with a Cardiac Mass

    The European Research Journal, 2026

    DOI 10.18621/eurj.1844523 Open-access full textSource: OpenAlex

  2. A Multi-Targeted Strategy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: Real-World Outcomes of the ViPOR Regimen

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15145401 PMID 42513315 Open-access full textSource: OpenAlex

  3. Real-World Effectiveness and Renal Safety of Foscarnet for CMV Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15166365 PMID 42652768 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  4. Knowledge, attitudes, and use of artificial intelligence among adult and pediatric hematologists in Türkiye: a national cross-sectional survey

    BMC Medical Education, 2026

    DOI 10.1186/s12909-026-10065-5 PMID 42958214 Open-access full textSource: ORCID

  5. Coronary bypass for acute coronary syndrome in severe hemophilia A

    Turk gogus kalp damar cerrahisi dergisi, 2026

    DOI 10.4274/tjtcs.2026.2026-7-38 PMID 42681991 Open-access full textSource: Europe PMC

  6. Risk Factors for Infectious Adverse Events in Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Venetoclax Combinations: A Retrospective Single‐Centre Real‐World Experience

    Cancer Reports, 2025

    DOI 10.1002/cnr2.70432 PMID 41431240 Open-access full textSource: ORCID

  7. Anemia in the patients with acute myeloid leukemia revisited: Prognostic importance of anemia on treatment-naïve patients

    Acta Medica, 2025

    DOI 10.32552/2025.actamedica.1135 Open-access full textSource: ORCID

  8. RISK FACTORS FOR INFECTIOUS ADVERSE EVENTS IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH VENETOCLAX COMBINATIONS: A RETROSPECTIVE SINGLE-CENTRE REAL-WORLD EXPERIENCE

    2025

    DOI 10.22541/au.173677335.55374696/v1 Open-access full textSource: ORCID

  9. Clinical Characteristics and Survival Outcomes in Patients with Essential Thrombocythemia

    Indian Journal of Hematology and Blood Transfusion, 2025

    DOI 10.1007/s12288-025-02198-2 PMID 42333154 Source: ORCID

  10. Comparison of anticoagulant combinations used in granulocyte apheresis

    Transfusion and Apheresis Science, 2025

    DOI 10.1016/j.transci.2024.104044 PMID 39662126 1 citation (Semantic Scholar) Open-access full textSource: ORCID

  11. Long-Term Outcomes of Allogeneic Stem Cell Transplantation for Relapsed/Refractory Hodgkin and Non-Hodgkin Lymphoma: Multi-center Experience from Turkey

    Indian Journal of Hematology and Blood Transfusion, 2025

    DOI 10.1007/s12288-024-01800-3 PMID 39917483 1 citation (Semantic Scholar) Open-access full textSource: ORCID

  12. The role of ruxolitinib in the management of acute GVHD

    Transfusion and Apheresis Science, 2025

    DOI 10.1016/j.transci.2024.104055 PMID 39719750 1 citation (Semantic Scholar) Open-access full textSource: ORCID

  13. Nilotinib-Associated Multiple Silent Arterial Stenoses in a Patient with Chronic Myeloid Leukemia

    The Turkish Journal of Hematology, 2024

    DOI 10.4274/tjh.galenos.2023.2023.0288 PMID 38153228 3 citations (Semantic Scholar) Open-access full textSource: ORCID

  14. Renin-Angiotensin System and Hematopoietic Stem Cells

    Reference Module in Biomedical Sciences, 2024

    DOI 10.1016/b978-0-443-15717-2.00122-0 Source: ORCID

  15. Coexistence of HHV-8-associated plasmacytic multicentric Castleman disease, Kaposi’s sarcoma, and multiple myeloma in a HIV-negative patient

    European Journal of Case Reports in Internal Medicine, 2024

    DOI 10.12890/2024_004876 PMID 39372151 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  16. Exploring the distribution and prognostic effect of the ABO blood types of COVID-19 patients during delta and omicron waves: A case control study

    Acta Medica, 2023

    DOI 10.32552/2023.actamedica.794 Open-access full textSource: ORCID

  17. A novel variant in severe disease of DADA2: involving vasculitic and haematologic features

    Scandinavian Journal of Rheumatology, 2023

    DOI 10.1080/03009742.2022.2095724 PMID 35852217 1 citation (Semantic Scholar) Source: ORCID

  18. Enterotoxins A and B produced by Staphylococcus aureus increase cell proliferation, invasion and cytarabine resistance in acute myeloid leukemia cell lines

    Heliyon, 2023

    DOI 10.1016/j.heliyon.2023.e19743 PMID 37810000 5 citations (Semantic Scholar) Open-access full textSource: ORCID

  19. Hypophosphatemia related to the use of ibrutinib

    Journal of Oncology Pharmacy Practice, 2023

    DOI 10.1177/10781552231164504 PMID 36987737 Source: ORCID

  20. Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center

    The Turkish Journal of Hematology, 2023

    DOI 10.4274/tjh.galenos.2023.2023.0089 PMID 37314288 4 citations (Semantic Scholar) Open-access full textSource: ORCID

  21. LONG-TERM OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED/REFRACTORY HODGKIN AND NON-HODGKIN LYMPHOMA: MULTI-CENTER EXPERINCE FROM TURKEY

    Hematology Transfusion and Cell Therapy, 2023

    DOI 10.1016/j.htct.2023.09.031 Open-access full textSource: OpenAlex

  22. Event-free Survival in Patients with Chronic Myeloid Leukemia Receiving Front-line Imatinib Mesylate

    Acta Medica, 2022

    DOI 10.32552/2022.actamedica.745 Open-access full textSource: ORCID

  23. Comment on Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874

    Medicina, 2022

    DOI 10.3390/medicina58111575 PMID 36363532 6 citations (Semantic Scholar) Open-access full textSource: ORCID

  24. Covid-19 Related Fatality and Risk Factors in Multiple Myeloma: A Multicenter Cohort Study

    UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, 2022

    DOI 10.4999/uhod.226339 Source: ORCID

  25. Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation

    Turkish Journal of Medical Sciences, 2022

    DOI 10.55730/1300-0144.5328 PMID 36161632 6 citations (Europe PMC) Open-access full textSource: ORCID

  26. Prophylactic Central Nervous System Irradiation Is Not Indispensable in Adult Patients with Acute Lymphoblastic Leukemia: A Multicenter Retrospective Cohort Study

    The Turkish Journal of Hematology, 2022

    DOI 10.4274/tjh.galenos.2022.2021.0680 PMID 35445593 Open-access full textSource: ORCID

  27. Publication pandemic

    European Respiratory Journal, 2022

    DOI 10.1183/13993003.congress-2022.3270 Source: ORCID

  28. Central nervous system involvement in patients with acute myeloid leukemia

    Turkish Journal of Medical Sciences, 2021

    DOI 10.3906/sag-2103-127 PMID 33932973 9 citations (Semantic Scholar) Open-access full textSource: ORCID

  29. Perspectives for immune plasma treatment of COVID-19

    Turkish Journal of Medical Sciences, 2021

    DOI 10.3906/sag-2005-410 PMID 32718128 5 citations (Semantic Scholar) Open-access full textSource: ORCID

  30. The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients

    Turkish Journal of Medical Sciences, 2021

    DOI 10.3906/sag-2103-72 PMID 33878857 10 citations (Semantic Scholar) Open-access full textSource: ORCID

  31. Covid-19 Pandemi Raporu (20 Mart-20 Kasım 2020)

    2021

    Source: OpenAlex

  32. İmmün (Konvalesan) Plazma Tedavisi

    Turkiye Klinikleri Hematology - Special Topics, 2021

    Source: OpenAlex

  33. Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis

    Transfusion and Apheresis Science, 2020

    DOI 10.1016/j.transci.2020.102821 PMID 32487513 48 citations (Semantic Scholar) Open-access full textSource: ORCID

  34. Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma

    Transfusion and Apheresis Science, 2020

    DOI 10.1016/j.transci.2020.102871 PMID 32694044 63 citations (Semantic Scholar) Open-access full textSource: ORCID

  35. COVID-19 Pandemisi Döneminde Hodgkin Lenfoma Yönetimi

    Türkiye Klinikleri COVID - 19, 2020

    Source: OpenAlex

  36. Some concerns and improvements from Turkey

    Annals of the Rheumatic Diseases, 2018

    DOI 10.1136/annrheumdis-2017-211963 PMID 28798052 Source: ORCID

  37. Akut Myeloid Lösemi Hastalarında İndüksiyon Kemoterapisinin Lösemi İlişkili Anemiye Etkisi

    Hacettepe University Institutional Repository (hacettepe.edu.tr), 2018

    Open-access full textSource: OpenAlex